Zdrowie i gospodarka · 29/12/2016

FDA Releases Draft Guidance on Compounding and Repackaging of Radiopharmaceuticals

The FDA has announced the availability of a draft guidance document outlining its policy on compounding and repackaging of radiopharmaceuticals by state-licensed nuclear pharmacies and federal facilities, aiming to provide clarity on the conditions under which the agency will not take enforcement action.